The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.

The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...

The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of 2020 and 2021 and an anticipated stock recovery in 2024 failed to materialise.

Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of biotechs chipping away at 2025’s iced-over IPO market. | Immunology biotech ...

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

Unprofitable biotech Veradermics, which still needs FDA approval for its hair loss pill, surged on its debut day.

Reported Standalone quarterly numbers for Windlas Biotech are: Net Sales at Rs 233.10 crore in December 2025 up 19.53% from ...

Department of Economic & Community Development Commissioner Daniel O'Keefe speaks at the BioCT legislative breakfast in New Haven on Jan. 27, 2025. Monday morning's annual legislative breakfast hosted ...

FAR Biotech, a computational drug discovery company, has officially relocated to Wisconsin. The move marks a significant milestone for the company, which is collaborating with the University ...

A major biotech company has announced plans to lay off more than 100 positions from its Franklin, Massachusetts, facility. According to a Workers Adjustment and Retraining Notification notice, layoffs ...